London [United Kingdom], April 25: At the Charing Cross Symposium 2026 this week, one theme kept resurfacing in quiet conversations between clinicians: what happens after the first year?
It’s a question that doesn’t always make headlines, but it tends to shape real-world decisions. The preliminary three-year data from the SIRONA randomised trial, presented by Prof. Ulf Teichgräber, leaned directly into that gap.
The study, backed by Concept Medical Inc., compares sirolimus-coated and paclitaxel-coated balloon angioplasty in…

![[CITYPNG.COM]White Google Play PlayStore Logo – 1500×1500](https://startupnews.thebackend.in/wp-content/uploads/2025/08/CITYPNG.COMWhite-Google-Play-PlayStore-Logo-1500x1500-1-630x630.png)